{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T13:59:38Z","timestamp":1791554378833,"version":"4.3.4"},"reference-count":38,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Centers for Disease Control and Prevention guidelines advocate reduced opioid prescribing for chronic pain, yet research on their implementation remains limited.<\/jats:p><\/jats:sec>Objective<\/jats:title>To compare 4 deimplementation strategies to promote guideline-concordant opioid prescribing.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This cluster randomized clinical trial was performed at 32 primary care clinics from 2 US health care systems from February 2020 to March 2022, using a hybrid type 3 sequential multiple-assignment design focused on patient outcomes. Clinics were recruited through volunteer sampling, including 268 clinicians and 8978 patients. Data were analyzed from September 2020 to March 2022. <\/jats:p><\/jats:sec>Intervention<\/jats:title>Deimplementation strategies were targeted at the system, clinic, and prescriber levels. All clinics received a system-level strategy consisting of quarterly educational meetings with monthly audit and feedback (EMAF) reports. At month 3, half the clinics were randomized to receive practice facilitation (PF), a clinic-level strategy that targets clinic workflows. At month 9, half the clinics were again randomized to add prescriber peer consulting (PPC), a prescriber-level strategy focused on challenging patient cases.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The primary outcome was change in mean morphine milligram equivalent (MME) dose in clinics receiving the least intensive bundle of deimplementation strategies (EMAF) vs the most intensive (EMAF plus PF plus PPC). Secondary outcomes included adherence to guideline metrics aimed at mitigating opioid risk.<\/jats:p><\/jats:sec>Results<\/jats:title>Among the 8978 patients included in the analysis, 5142 (57.3%) were female; 42 (0.5%), American Indian or Alaska Native; 74 (0.8%), Asian or Pacific Islander; 411 (4.6%), Black; 187 (2.1%), Hispanic or Latino; 8127 (90.5%), White; and 137 (1.5%), other or unknown. Mean (SD) age was 58.3 (14.3) years. Eight clinics (including 66 prescibers and 2044 patients) assigned the most intensive strategy (EMAF plus PF plus PPC) had statistically significant effects on the primary outcome compared with 7 clinics (including 60 clinicians and 2427 patients) receiving the least intensive strategy (EMAF); clinics in the high-intensity group decreased the mean MME dose by 2.4 (95% CI, \u22124.3 to \u22120.5) mg\/d more than the EMAF group (P<\/jats:italic>\u2009=\u2009.02), representing a 6% reduction, and increased screening for pain severity, enjoyment of life, and general activity by 5.4% (95% CI, 0.4%-10.4% [P<\/jats:italic>\u2009=\u2009.04]) more. Compared with EMAF, the most intensive strategy resulted in statistically significant decreases in urine drug screening (difference, \u22127.3% [95% CI, \u221211.5% to \u22123.0%]; P<\/jats:italic>\u2009&amp;lt;\u2009.001) and use of treatment agreements (difference, \u22126.7% [95% CI, \u221211.1 to \u22122.3%]; P<\/jats:italic>\u2009=\u2009.003), in the opposite direction of the hypothesis. There were no significant differences between groups in benzodiazepine coprescribing, mental health screening, or patients receiving an MME dose greater than or equal to 90.0 mg\/d.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this cluster randomized clinical trial, a high-intensity deimplementation strategy targeted at prescribers significantly decreased the MME dose and increased screening for pain intensity and pain-related interference while reducing use of treatment agreements and urine drug screening. Providing clinic- and prescriber-level deimplementation strategies may help health systems take positive steps toward reducing reliance on opioid medications for chronic pain management in primary care settings.<\/jats:p><\/jats:sec>Trial Registration<\/jats:title>ClinicalTrials.gov Identifier: NCT04044521<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.38325","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T15:07:44Z","timestamp":1728572864000},"page":"e2438325","source":"Crossref","is-referenced-by-count":8,"title":["Strategies to Deimplement Opioid Prescribing in Primary Care"],"prefix":"10.1001","volume":"7","author":[{"given":"Andrew","family":"Quanbeck","sequence":"first","affiliation":[{"name":"Department of Family Medicine and Community Health, University of Wisconsin\u2013Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Robinson","sequence":"additional","affiliation":[{"name":"Forward Data Analytic Services, LLC, Verona, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Jacobson","sequence":"additional","affiliation":[{"name":"Institute for Clinical and Translational Research and School of Nursing, University of Wisconsin\u2013Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Family Medicine and Community Health, University of Wisconsin\u2013Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Hennessy-Garza","sequence":"additional","affiliation":[{"name":"Zilber College of Public Health, University of Wisconsin\u2013Milwaukee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Landeck","sequence":"additional","affiliation":[{"name":"Department of Family Medicine and Community Health, University of Wisconsin\u2013Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Cohen","sequence":"additional","affiliation":[{"name":"Bellin Health, Green Bay, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Madden","sequence":"additional","affiliation":[{"name":"APT Foundation, North Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Pulvermacher","sequence":"additional","affiliation":[{"name":"Department of Family Medicine and Community Health, University of Wisconsin\u2013Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Family Medicine and Community Health, University of Wisconsin\u2013Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,10,10]]},"reference":[{"issue":"15","key":"zoi241109r1","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1001\/jama.289.15.1969","article-title":"Disseminating innovations in health care.","volume":"289","author":"Berwick","year":"2003","journal-title":"JAMA"},{"issue":"2","key":"zoi241109r2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1056\/NEJM198001103020221","article-title":"Addiction rare in patients treated with narcotics.","volume":"302","author":"Porter","year":"1980","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi241109r3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40122-018-0097-6","article-title":"A brief history of the opioid epidemic and strategies for pain medicine.","volume":"7","author":"Jones","year":"2018","journal-title":"Pain Ther"},{"issue":"1","key":"zoi241109r4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016.","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"zoi241109r6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC Clinical practice guideline for prescribing opioids for pain\u2014United States, 2022.","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"zoi241109r8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1370\/afm.1312","article-title":"Systematic review and meta-analysis of practice facilitation within primary care settings.","volume":"10","author":"Baskerville","year":"2012","journal-title":"Ann Fam Med"},{"issue":"1","key":"zoi241109r9","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12916-020-01567-0","article-title":"Engaging patients in de-implementation interventions to reduce low-value clinical care: a systematic review and meta-analysis.","volume":"18","author":"Sypes","year":"2020","journal-title":"BMC Med"},{"issue":"1","key":"zoi241109r10","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13012-021-01173-5","article-title":"A scoping review of de-implementation frameworks and models.","volume":"16","author":"Walsh-Bailey","year":"2021","journal-title":"Implement Sci"},{"issue":"1","key":"zoi241109r11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13012-019-0960-9","article-title":"Unpacking the complexities of de-implementing inappropriate health interventions.","volume":"15","author":"Norton","year":"2020","journal-title":"Implement Sci"},{"issue":"1","key":"zoi241109r12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13012-020-00990-4","article-title":"The Balanced Opioid Initiative: protocol for a clustered, sequential, multiple-assignment randomized trial to construct an adaptive implementation strategy to improve guideline-concordant opioid prescribing in primary care.","volume":"15","author":"Quanbeck","year":"2020","journal-title":"Implement Sci"},{"issue":"4","key":"zoi241109r14","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1080\/15374416.2016.1152555","article-title":"Adaptive Interventions in Child and Adolescent Mental Health.","volume":"45","author":"Almirall","year":"2016","journal-title":"J Clin Child Adolesc Psychol"},{"issue":"1","key":"zoi241109r15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13012-018-0808-8","article-title":"Adaptive school-based implementation of CBT (ASIC): clustered-SMART for building an optimized adaptive implementation intervention to improve uptake of mental health interventions in schools.","volume":"13","author":"Kilbourne","year":"2018","journal-title":"Implement Sci"},{"issue":"1","key":"zoi241109r16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13012-018-0713-1","article-title":"A randomized matched-pairs study of feasibility, acceptability, and effectiveness of systems consultation: a novel implementation strategy for adopting clinical guidelines for opioid prescribing in primary care.","volume":"13","author":"Quanbeck","year":"2018","journal-title":"Implement Sci"},{"issue":"1","key":"zoi241109r17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13012-015-0209-1","article-title":"A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change (ERIC) project.","volume":"10","author":"Powell","year":"2015","journal-title":"Implement Sci"},{"issue":"1","key":"zoi241109r18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1748-5908-8-139","article-title":"Implementation strategies: recommendations for specifying and reporting.","volume":"8","author":"Proctor","year":"2013","journal-title":"Implement Sci"},{"issue":"2","key":"zoi241109r19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jpsychores.2004.09.006","article-title":"Detecting and monitoring depression with a two-item questionnaire (PHQ-2).","volume":"58","author":"L\u00f6we","year":"2005","journal-title":"J Psychosom Res"},{"issue":"6","key":"zoi241109r20","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s11606-009-0981-1","article-title":"Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference.","volume":"24","author":"Krebs","year":"2009","journal-title":"J Gen Intern Med"},{"issue":"1","key":"zoi241109r21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.5539\/ass.v11n1p239","article-title":"The Deming cycle (PDCA) concept as an efficient tool for continuous quality improvement in the agribusiness.","volume":"11","author":"Dudin","year":"2014","journal-title":"Asian Soc Sci"},{"issue":"6402","key":"zoi241109r22","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1126\/science.aat4595","article-title":"Opioid prescribing decreases after learning of a patient\u2019s fatal overdose.","volume":"361","author":"Doctor","year":"2018","journal-title":"Science"},{"issue":"1","key":"zoi241109r23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41467-023-44573-5","article-title":"A randomized trial looking at planning prompts to reduce opioid prescribing.","volume":"15","author":"Doctor","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"zoi241109r24","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1038\/s41598-024-52032-4","article-title":"Reductions in sustained prescription opioid use within the US between 2017 and 2021.","volume":"14","author":"Schoenfeld","year":"2024","journal-title":"Sci Rep"},{"issue":"15","key":"zoi241109r25","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s40265-020-01368-y","article-title":"Deprescribing opioids in chronic non-cancer pain: systematic review of randomised trials.","volume":"80","author":"Mathieson","year":"2020","journal-title":"Drugs"},{"issue":"9","key":"zoi241109r26","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1001\/jamainternmed.2017.2468","article-title":"Improving adherence to long-term opioid therapy guidelines to reduce opioid misuse in primary care: a cluster-randomized clinical trial.","volume":"177","author":"Liebschutz","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"20","key":"zoi241109r27","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1001\/jama.2023.6454","article-title":"Reducing opioid use for chronic pain with a group-based intervention: a randomized clinical trial.","volume":"329","author":"Sandhu","year":"2023","journal-title":"JAMA"},{"issue":"10","key":"zoi241109r28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003796","article-title":"The effects of an evidence- and theory-informed feedback intervention on opioid prescribing for non-cancer pain in primary care: a controlled interrupted time series analysis.","volume":"18","author":"Alderson","year":"2021","journal-title":"PLoS Med"},{"issue":"12","key":"zoi241109r29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009993","article-title":"Achieving change in primary care\u2013effectiveness of strategies for improving implementation of complex interventions: systematic review of reviews.","volume":"5","author":"Lau","year":"2015","journal-title":"BMJ Open"},{"issue":"20","key":"zoi241109r30","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1001\/jama.2023.6539","article-title":"Prescribing opioids for pain.","volume":"329","author":"Ari","year":"2023","journal-title":"JAMA"},{"issue":"13","key":"zoi241109r31","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose\u2013related deaths.","volume":"305","author":"Bohnert","year":"2011","journal-title":"JAMA"},{"issue":"5","key":"zoi241109r32","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1001\/jama.2021.11013","article-title":"Association of dose tapering with overdose or mental health crisis among patients prescribed long-term opioids.","volume":"326","author":"Agnoli","year":"2021","journal-title":"JAMA"},{"issue":"8","key":"zoi241109r33","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.26523","article-title":"Comparative effectiveness of opioid tapering or abrupt discontinuation vs no dosage change for opioid overdose or suicide for patients receiving stable long-term opioid therapy.","volume":"5","author":"Larochelle","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"24","key":"zoi241109r34","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1056\/NEJMp1904190","article-title":"No shortcuts to safer opioid prescribing.","volume":"380","author":"Dowell","year":"2019","journal-title":"N Engl J Med"},{"issue":"2","key":"zoi241109r35","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1080\/08897077.2019.1692122","article-title":"Beneficial opioid management strategies: a review of the evidence for the use of opioid treatment agreements.","volume":"41","author":"McAuliffe Staehler","year":"2020","journal-title":"Subst Abus"},{"key":"zoi241109r36","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108664","article-title":"\u201cI felt like I had a scarlet letter\u201d: recurring experiences of structural stigma surrounding opioid tapers among patients with chronic, non-cancer pain.","volume":"222","author":"Benintendi","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"zoi241109r37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.5055\/jom.2023.0802","article-title":"Shifting quality chronic pain treatment measures from processes to outcomes.","volume":"19","author":"Coleman","year":"2023","journal-title":"J Opioid Manag"},{"key":"zoi241109r38","doi-asserted-by":"publisher","first-page":"h2147","DOI":"10.1136\/bmj.h2147","article-title":"The PRECIS-2 tool: designing trials that are fit for purpose.","volume":"350","author":"Loudon","year":"2015","journal-title":"BMJ"},{"key":"zoi241109r7","volume-title":"Clinical Practice Guidelines We Can Trust","author":"Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines","year":"2011"},{"key":"zoi241109r13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-3-319-91776-4_4","volume-title":"Optimization of Behavioral, Biobehavioral, and Biomedical Interventions","author":"Almirall","year":"2018"},{"key":"zoi241109r5","unstructured":"Centers for Disease Control and Prevention. Overdose prevention. Accessed November 16, 2023. https:\/\/www.cdc.gov\/overdose-prevention\/?CDC_AAref_Val=https:\/\/www.cdc.gov\/opioids\/healthcare-professionals\/prescribing\/guideline\/index.html"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2824679\/quanbeck_2024_oi_241109_1727811825.52308.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T15:07:49Z","timestamp":1728572869000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2824679"}},"subtitle":["A Cluster Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2024,10,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.38325","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,10]]}}}